The present article reviews the studies so far published on the psychopharm
acological effects mediated by tachykinin NK-3 receptors in laboratory anim
als. Central administration of NK-3 receptor agonists has been reported to
attenuate alcohol intake in alcohol-preferring rats and to evoke conditione
d place preference. These findings suggest that NK-3 receptors may affect r
eward processes to drugs of abuse. Anxiolytic-like and antidepressant-like
effects have been previously reported for NK-1 receptor antagonists, and an
xiolytic-like effects for NK-2 receptor antagonists. More recently, it has
been shown that NK-3 receptor agonists have anxiolytic-like and antidepress
ant-like effects in mice and rats, while an NK-3 receptor antagonist was re
ported to be anxiogenic in mice. These findings indicate that different TK
receptor subtypes may be involved in anxiolytic-like and antidepressant-lik
e effects in laboratory animals and raise interest for the possible role of
NK-3 receptors in the control of anxiety and depression in man. (C) 2000 E
lsevier Science Inc. All rights reserved.